These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1286487)

  • 1. Glyburide versus glipizide in the treatment of patients with non-insulin-dependent diabetes mellitus.
    Kilo C; Meenan A; Bloomgarden Z
    Clin Ther; 1992; 14(6):801-12. PubMed ID: 1286487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter comparison of glyburide and glipizide in the treatment of non-insulin-dependent diabetes mellitus.
    Kilo C
    Clin Ther; 1988; 10(3):294-302. PubMed ID: 3152586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes control in the elderly: a randomized, comparative study of glyburide versus glipizide in non-insulin-dependent diabetes mellitus.
    Rosenstock J; Corrao PJ; Goldberg RB; Kilo C
    Clin Ther; 1993; 15(6):1031-40. PubMed ID: 8111800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and risks with glyburide and glipizide in elderly NIDDM patients.
    Brodows RG
    Diabetes Care; 1992 Jan; 15(1):75-80. PubMed ID: 1737544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
    Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
    JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of glipizide and glyburide in a health maintenance organization.
    Noyes MA; Carter BL; Helling DK; McCormick WC; Ramirez R
    Ann Pharmacother; 1992 Oct; 26(10):1215-20. PubMed ID: 1421641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus.
    Kitabchi AE; Kaminska E; Fisher JN; Sherman A; Pitts K; Bush A; Bryer-Ash M
    Am J Med Sci; 2000 Mar; 319(3):143-8. PubMed ID: 10746824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
    Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
    Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.
    Groop L; Groop PH; Stenman S; Saloranta C; Tötterman KJ; Fyhrquist F; Melander A
    Diabetes Care; 1987; 10(6):671-8. PubMed ID: 3123184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control and hypoglycemia in Veterans Health Administration patients converted from glyburide to glipizide.
    Skoff RA; Waterbury NV; Shaw RF; Egge JA; Cantrell M
    J Manag Care Pharm; 2011 Nov; 17(9):664-71. PubMed ID: 22050391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.
    Birkeland KI; Furuseth K; Melander A; Mowinckel P; Vaaler S
    Diabetes Care; 1994 Jan; 17(1):45-9. PubMed ID: 8112188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
    Lev JD; Zeidler A; Kumar D
    Diabetes Care; 1987; 10(6):679-82. PubMed ID: 3123183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy.
    Jaber LA; Lewis NJ; Slaughter RL; Neale AV
    J Clin Pharmacol; 1993 Mar; 33(3):239-45. PubMed ID: 8463437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus.
    Rosenstock J; Meisel A; Raskin P
    Am J Med; 1987 Sep; 83(3A):10-5. PubMed ID: 3307402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
    Goldstein BJ; Pans M; Rubin CJ
    Clin Ther; 2003 Mar; 25(3):890-903. PubMed ID: 12852706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
    Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
    Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.
    Berelowitz M; Fischette C; Cefalu W; Schade DS; Sutfin T; Kourides IA
    Diabetes Care; 1994 Dec; 17(12):1460-4. PubMed ID: 7882817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.
    Madsbad S; Kilhovd B; Lager I; Mustajoki P; Dejgaard A;
    Diabet Med; 2001 May; 18(5):395-401. PubMed ID: 11472451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.